ALDH1A1 and cancer: revealed that tamoxifen functioned as an ERα36 agonist to upregulate the expression of aldehyde dehydrogenase 1A1 (ALDH1A1) in CSCs, which plays a pivotal role in the maintenance of cancer stemness properties (32).